Boulegeris Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-9,425
Closed -$202K 51
2016
Q1
$202K Buy
9,425
+50
+0.5% +$1.07K 0.14% 51
2015
Q4
$296K Sell
9,375
-8,865
-49% -$280K 0.21% 40
2015
Q3
$628K Buy
18,240
+825
+5% +$28.4K 0.48% 34
2015
Q2
$548K Buy
17,415
+915
+6% +$28.8K 0.39% 35
2015
Q1
$484K Buy
16,500
+5,425
+49% +$159K 0.36% 37
2014
Q4
$205K Buy
+11,075
New +$205K 0.16% 45